assembly Bill A459

2011-2012 Legislative Session

Creates an education and outreach program for the autoimmune disease known as lupus

download bill text pdf

Sponsored By

Archive: Last Bill Status - Passed Assembly


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (15)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jan 10, 2012 referred to health
delivered to senate
passed assembly
Jan 04, 2012 ordered to third reading cal.24
returned to assembly
died in senate
Jun 17, 2011 referred to rules
delivered to senate
passed assembly
ordered to third reading rules cal.428
rules report cal.428
reported
reported referred to rules
May 10, 2011 reported referred to ways and means
Jan 05, 2011 referred to health

Co-Sponsors

view additional co-sponsors

Multi-Sponsors

view additional multi-sponsors

A459 (ACTIVE) - Details

See Senate Version of this Bill:
S5114
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Amd ยง207, Pub Health L
Versions Introduced in Other Legislative Sessions:
2009-2010: A8884, S3679
2013-2014: A544, A8461, S5178
2015-2016: A3072, S5216

A459 (ACTIVE) - Summary

Creates an education and outreach program for the autoimmune disease known as lupus; provides for an advisory council consisting of representatives of people with lupus and their families and health care providers who specialize in treating lupus.

A459 (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                   459

                       2011-2012 Regular Sessions

                          I N  A S S E M B L Y

                               (PREFILED)

                             January 5, 2011
                               ___________

Introduced  by M. of A. GIBSON, JAFFEE, CASTRO, SPANO, ROBINSON, BARRON,
  CRESPO, ORTIZ -- Multi-Sponsored by  --  M.  of  A.  DESTITO,  HOOPER,
  JEFFRIES,  LIFTON, McENENY, PEOPLES-STOKES, PERRY, PHEFFER, ROSENTHAL,
  SCARBOROUGH, SWEENEY, TITONE -- read once and referred to the  Commit-
  tee on Health

AN  ACT  to amend the public health law, in relation to the lupus educa-
  tion and outreach program

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Legislative  intent.  The  legislature  hereby  finds the
following:
  (a) Lupus is a serious, complex, debilitating autoimmune disease  that
can  cause  inflammation and tissue damage to virtually any organ system
in the body, including the skin, joints, other connective tissue,  blood
and blood vessels, heart, lungs, kidney, and brain.
  (b)  Lupus research estimates that approximately one and a half to two
million Americans live with some form of lupus; lupus affects women nine
times more often than men and eighty percent of newly diagnosed cases of
lupus develop among women of childbearing age.
  (c) Lupus disproportionately affects women of color -- it  is  two  to
three  times  more common among African-Americans, Hispanics, Asians and
Native Americans and is generally more prevalent in minority populations
-- a health disparity that remains unexplained. According to the Centers
for Disease Control and Prevention  the  rate  of  lupus  mortality  has
increased  since the late 1970s and is higher among older African-Ameri-
can women.
  (d) No new drugs have been approved by the U.S. Food and Drug Adminis-
tration specifically for lupus in nearly forty years and  while  current
treatments  for  the disease can be effective, they can lead to damaging
side effects.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.